Figure 1: The PXRD pattern of Ceo2 Nanoparticles
| Samples | Cellparameters (Å) | d space (Å) | Volume (Å)3 | Crystalline size (nm) | Structure | ||
| C1 | 5.4 | 1.759 | 158 | 49.1 | FCC | ||
| samples | JCPDS CardNo. |
D-Spacing (Å) | Cell Parameters (Å) | Cell Volume (Å)3 | |||
| Ca lculations | JCPDS | Ca lculations | JCPDS | Calculations | JCPDS | ||
| CeO2 | 81-0792 | 1.7596 | J.7609 | 5.408 | 5.412 | 158.34 | 158.55 |
Table 1: The deduced magnetic parameters for CoCexFe2-xO4 (0.0≤ x≤0.10) samples obtained from the M-H loops at 100 K
| Area (nm) | Mean (nm) | Min (nm) | Max (nm) |
| 148.556 | 86.527 | 10.288 | 251 |
| 147.663 | 71.1 | 26.583 | 253.647 |
| 146.005 | 85.089 | 21.012 | 145 |
| 145.112 | 79.468 | 16.884 | 121 |
| Average = 46.S nm | |||
Table 2: The size distributions of CeO2 NPs
| Spectrum:Spectrum 525-Ce | ||||||
| Element Series | ., Net |
mn.C (% .Wt) | 'iorm. C (% .Wt) | Atom. C (% .at) | Error (% .Sigma) (Wt 3) |
|
| Cerium | L-series | 4064 | B9.31 | 9.31 | 48.83 | 26.9 |
| Oxygen | K-series | 13405 | 10.69 | 10.69 | 51.17 | l.08 |
| Tota l: 100.00 100.00 100.0 | ||||||
Table 3: The percentage of chemical elements in the synthesized Ceo2.NPs sample
| Observed Band Position (cm)-1 | Assignments |
| 1311 | C-N Stretching vibration |
| 1647 | C=C Stretching vibration |
| 3428 | O-H Stretching vibration |
| 425, 706 | Cerium Oxide |
Table 4: Top ten keywords and frequency
| Nanoparticle | Aspergilus % of Zone inhibition | |||
| Ceo2 Nanoparticles | Concentration | Control | ||
| 100 mg | 200 mg | 300 mg | 17 mm | |
| 12 mm | 13mm | IS mm | ||
| Mucor % of Zone inhibition | ||||
| Concentration | Control | |||
| 100 mg | 200 mg | 300 mg | 22 nun | |
| 14 mm | 18 nun | 20 mm | ||
Table 5: Anti-Bactria of Cerium Oxide (Ceo2)
| Nanoparticle | Aspergilus % of Zone inhibition | |||
| Ceo2 Nanoparticles | Concentration | Control | ||
| 100 mg | 200 mg | 300 mg | 17 mm | |
| 12 mm | 13mm | IS mm | ||
| Mucor % of Zone inhibition | ||||
| Concentration | Control | |||
| 100 mg | 200 mg | 300 mg | 22 nun | |
| 14 mm | 18 nun | 20 mm | ||
| Nanopartide | BACILLUS SP % of Zone inhibition | |||
| Ce02 Nanopartides | Concentration | Control | ||
| 100 mg | 200 mg | 300 mg | 19 mm | |
| 14 mm | 15 mm | 17 mm | ||
| E. COLI % of Zone inhibition | ||||
| Concentration | Control | |||
| 100 mg | 200 mg | 300 mg | 24 mm | |
| 16 mm | 20111m | 22 mg | ||
Table 6: Anti-Bactria of Cerium Oxide (Ceo2)
| Sample Particulars | ||||
| Description | Conc. (μg) |
Cytotoxicity(%) | Cell viability(%) | Cell viability(%) |
| Cl | 5 | 86 | 14 | Severe |
| 10 | 83 | 17 | Severe | |
| 50 | 76 | 24 | Severe | |
| 75 | 77 | 23 | Severe | |
| 100 | 80 | 20 | Severe | |
Table 7: Anti-Bactria of Cerium Oxide (Ceo2.)
Figure 1: The PXRD pattern of Ceo2 Nanoparticles
Figure 2: TEM images of Cerium Oxide (Ceo2) Nanoparticles
Figure 3: The EDX pattern of Ceo2 Nanoparticles
Figure 4: FTIR spectrum of Cerium Oxide (Ceo2)
Figure 5a: UV-Vis absorbance spectra of Ceo2 NPs
Figure 5b: UV-Vis transmittance spectra of Ceo2 NPs
Figure 5c: Photon energy vs.(ahv)2spectrum of Ceo2 NPs
Figure 6: PL spectra of Ceo NPs
Figure 7: Anti-Fungal activity of Cerium Oxide (CeO)
Figure 8: Anti-Bactria of Cerium Oxide (Ceo)
Figure 9: Anti-Bactria of Cerium Oxide (CeO2).
Figure 10: Anti-Bactria of Cerium Oxide (CeO2)
Figure 11: Anti-Bactria of Cerium Oxide (CeO2)
Tables at a glance
Figures at a glance